Skip to content
lsd.com

Indication

Depression Disorder

4 registered trials testing Psilocybin, Ketamine for this indication, 3 recruiting now.

4
Registered trials
3
Recruiting
1
In Phase 3

Substances tested

Being studied with

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Depression Disorder trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 4 trials for Depression Disorder

TrialStatusPhaseSubstanceSites
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderNCT06793397 · Cybin IRL LimitedRecruitingPhase 3psilocybin68
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit PatientsNCT07639359 · Hospital Italiano de Buenos AiresRecruitingPhase 2ketamine2
Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant DepressionNCT07422519 · Hospital Universitari Vall d'Hebron Research InstituteRecruitingNot applicableketamine1
Link Between Reduction of Suicide Ideation by Esketamine in Add-On and Initial Levels of Psychological Pain and AnhedoniaNCT07199179 · University Hospital, MontpellierActive, not recruitingN/Aketamine1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.